Back

Economic impact of ivabradine use in the vulnerable phase: results from the ROCI registry

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Clara Ines Saldarriaga

Cardio Clinical VID, Medellin (Colombia)

22 More presentations in this session

Presentation thumbnail
Nationwide trends in prevalence and incidence of and 3-year mortality in hospitalized heart failure patients in Taiwan (2010-2015): lingering hazards remain
Professor T. Wang (Taipei, TW)
Abstract Slides
Presentation thumbnail
Modes of death in cardiac amyloidosis
Ms C. Binder (Vienna, AT)
Abstract
Presentation thumbnail
Liver-specific microRNA-122 as a prognostic biomarker in patients with chronic heart failure
Associate Professor S. Stojkovic (Vienna, AT)
Abstract Slides
Presentation thumbnail
Genetics in heart failure prognosis: does it make a difference?
Mr A. Ulitin (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
What is the meaning of pericardial effusion in the general population? Results from the STAAB cohort study
Doctor M. Breunig (Wuerzburg, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources